DCT

2:18-cv-16035

Celgene Corp v. Mylan Pharma Inc

General
Filed
11/09/18
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Judge
Period
PO Win Rate
--
57%